View All Key Stats
VSTM Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.11 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -41.15M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 130.58M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 2.159 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -10.65M |
| Return on Equity (TTM) | -- |
View All VSTM News
VSTM News
-
WireHeadlineTime (ET)
-
Yahoo07/21 17:39
-
PR Newswire07/21 06:10
-
SA Breaking News07/20 17:35
-
Yahoo07/13 08:10
-
SA Breaking News07/12 12:37
-
MT Newswires07/11 16:14
-
SA Breaking News07/11 16:08
-
Business Wire07/11 16:05
-
SA Breaking News07/11 14:26
-
SA Breaking News07/07 09:12
View All Events
VSTM Events
| Date | Type | Description |
|---|---|---|
| 05/17/2017 | Misc | Verastem Inc Annual General Meeting in 2016 |
| 05/10/2017 | Earnings | Verastem Inc First Quarter Earnings Results in 2017 |
| 03/23/2017 16:30 EDT | Misc | Verastem Inc Fourth Quarter Earnings Conference Call in 2017 |
| 03/23/2017 | Earnings | Verastem Inc Fourth Quarter Earnings in 2017 Release |
| 02/14/2017 09:00 EDT | Misc | Verastem Announces Reduction of Workforce |
| 12/03/2016 | Misc | Verastem Inc Annual General Meeting in 2015 |
| 11/07/2016 | Earnings | Verastem Inc Third Quarter Earnings Results in 2016 |
| 08/08/2016 | Earnings | Verastem Inc Second Quarter Earnings Results in 2016 |
VSTM Fundamentals
Income Statement View Statement
VSTM Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
VSTM One Page Reports
- One Page Report Download
VSTM Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 3.53 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.verastem.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 10, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib (VS-6063).
VSTM Comparables
EditVSTM Excel Add-In Codes
- Name: =YCI("VSTM","name")
- Description: =YCI("VSTM","description")
- Sector: =YCI("VSTM","sector")
- Industry: =YCI("VSTM","industry")
- Est. Current Fiscal Year End: =YCI("VSTM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other VSTM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VSTM Tweets Stocktwits
Advertisement
